- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Research and Development
Research and Development is a vital component of our Business Strategy providing the competitive advantage. We recognize INNOVATION as the key to success and have been working as a research driven entity over the last decade.
Our working environment nurtures excellence and innovation which are the pillars on which our organization is built. REVA view’s its research capabilities as a vital component to its market access, customer servicing and therapies of growth.
At Reva we work closely with the business to generate innovative concepts and ideas, exploiting both market needs and synergies across therapeutic areas.
- Joint Development
- API Technology
- FDF Technology
- New Drug Treatments
- Define and Design Processes